These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 15148857)
1. Blood phenylalanine control in adolescents with phenylketonuria. Walter JH; White FJ Int J Adolesc Med Health; 2004; 16(1):41-5. PubMed ID: 15148857 [TBL] [Abstract][Full Text] [Related]
2. Blood Phenylalanine Levels in Patients with Phenylketonuria from Europe between 2012 and 2018: Is It a Changing Landscape? Pinto A; Ahring K; Almeida MF; Ashmore C; Bélanger-Quintana A; Burlina A; Coşkun T; Daly A; van Dam E; Dursun A; Evans S; Feillet F; Giżewska M; Gökmen-Özel H; Hickson M; Hoekstra Y; Ilgaz F; Jackson R; Leśniak A; Loro C; Malicka K; Patalan M; Rocha JC; Sivri S; Rodenburg I; van Spronsen F; Strączek K; Tokatli A; MacDonald A Nutrients; 2024 Jun; 16(13):. PubMed ID: 38999811 [TBL] [Abstract][Full Text] [Related]
3. An automated enzymatic method on the Roche COBAS MIRA S for monitoring phenylalanine in dried blood spots of patients with phenylketonuria. Randell EW; Lehotay DC Clin Biochem; 1996 Apr; 29(2):133-8. PubMed ID: 8601321 [TBL] [Abstract][Full Text] [Related]
4. Work activity and phenylalanine levels in a population of young adults with classic PKU. Riva MA; Madotto F; Turato M; Salvatici E; Indovina S; Giovannini M; Riva E; Cesana G Med Lav; 2017 Apr; 108(2):118-122. PubMed ID: 28446738 [TBL] [Abstract][Full Text] [Related]
5. Adherence to clinic recommendations among patients with phenylketonuria in the United States. Jurecki ER; Cederbaum S; Kopesky J; Perry K; Rohr F; Sanchez-Valle A; Viau KS; Sheinin MY; Cohen-Pfeffer JL Mol Genet Metab; 2017 Mar; 120(3):190-197. PubMed ID: 28162992 [TBL] [Abstract][Full Text] [Related]
6. Therapy compliance in children with phenylketonuria younger than 5 years: A cohort study. Walkowiak D; Bukowska-Posadzy A; Kałużny Ł; Ołtarzewski M; Staszewski R; Musielak M; Walkowiak J Adv Clin Exp Med; 2019 Oct; 28(10):1385-1391. PubMed ID: 31469949 [TBL] [Abstract][Full Text] [Related]
7. Plasma cholesterol in adults with phenylketonuria. Williams RA; Hooper AJ; Bell DA; Mamotte CD; Burnett JR Pathology; 2015 Feb; 47(2):134-7. PubMed ID: 25551302 [TBL] [Abstract][Full Text] [Related]
8. Blood-brain phenylalanine relationships in persons with phenylketonuria. Koch R; Moats R; Guttler F; Guldberg P; Nelson M Pediatrics; 2000 Nov; 106(5):1093-6. PubMed ID: 11061780 [TBL] [Abstract][Full Text] [Related]
9. Induction, titration, and maintenance dosing regimen in a phase 2 study of pegvaliase for control of blood phenylalanine in adults with phenylketonuria. Zori R; Thomas JA; Shur N; Rizzo WB; Decker C; Rosen O; Li M; Schweighardt B; Larimore K; Longo N Mol Genet Metab; 2018 Nov; 125(3):217-227. PubMed ID: 30146451 [TBL] [Abstract][Full Text] [Related]
10. Stability of blood phenylalanine levels and IQ in children with phenylketonuria. Anastasoaie V; Kurzius L; Forbes P; Waisbren S Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366 [TBL] [Abstract][Full Text] [Related]
11. "MY PKU": increasing self-management in patients with phenylketonuria. A randomized controlled trial. Ten Hoedt AE; Hollak CE; Boelen CC; van der Herberg-van de Wetering NA; Ter Horst NM; Jonkers CF; Wijburg FA; Bosch AM Orphanet J Rare Dis; 2011 Jun; 6():48. PubMed ID: 21708003 [TBL] [Abstract][Full Text] [Related]
12. Blood phenylalanine control in phenylketonuria: a survey of 10 European centres. Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen-Ozel H; Lammardo AM; MacDonald A; Motzfeldt K; Nowacka M; Robert M; van Rijn M Eur J Clin Nutr; 2011 Feb; 65(2):275-8. PubMed ID: 21119696 [TBL] [Abstract][Full Text] [Related]
13. Carnitine status in early-treated children, adolescents and young adults with phenylketonuria on low phenylalanine diets. Weigel C; Kiener C; Meier N; Schmid P; Rauh M; Rascher W; Knerr I Ann Nutr Metab; 2008; 53(2):91-5. PubMed ID: 18946205 [TBL] [Abstract][Full Text] [Related]
14. Executive functioning in children and adolescents with phenylketonuria. VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394 [TBL] [Abstract][Full Text] [Related]
15. Factors that increase risk for poor adherence to phenylketonuria treatment in Brazilian patients. Teruya KI; Remor E; Schwartz IVD Am J Med Genet A; 2021 Jul; 185(7):1991-2002. PubMed ID: 33765361 [TBL] [Abstract][Full Text] [Related]
16. Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes. MacLeod EL; Gleason ST; van Calcar SC; Ney DM Mol Genet Metab; 2009 Dec; 98(4):331-7. PubMed ID: 19747868 [TBL] [Abstract][Full Text] [Related]
17. Long-term treatment of phenylketonuria with a new medical food containing large neutral amino acids. Concolino D; Mascaro I; Moricca MT; Bonapace G; Matalon K; Trapasso J; Radhakrishnan G; Ferrara C; Matalon R; Strisciuglio P Eur J Clin Nutr; 2017 Jan; 71(1):51-55. PubMed ID: 27623981 [TBL] [Abstract][Full Text] [Related]
18. Outcomes beyond phenylalanine: an international perspective. Feillet F; MacDonald A; Hartung Perron D; Burton B Mol Genet Metab; 2010; 99 Suppl 1():S79-85. PubMed ID: 20123476 [TBL] [Abstract][Full Text] [Related]
19. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control? Daly A; Evans S; Chahal S; Santra S; MacDonald A J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827 [TBL] [Abstract][Full Text] [Related]
20. Does maternal knowledge impact blood phenylalanine concentration in Turkish children with phenylketonuria? Ozel HG; Kucukkasap T; Koksal G; Sivri HS; Dursun A; Tokatli A; Coskun T J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S213-7. PubMed ID: 18581253 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]